LI Hongqin, CHEN Bo, JIANG Guilin, ZHANG Jingjing, SHI Huanyu, HUO Changliang. Clinical observation and nursing of Chinese medicine combined with recombinant interleukin-11 in treating refractory idiopathic thrombocytopenic purpura[J]. Journal of Clinical Medicine in Practice, 2014, (22): 31-34. DOI: 10.7619/jcmp.201422010
Citation: LI Hongqin, CHEN Bo, JIANG Guilin, ZHANG Jingjing, SHI Huanyu, HUO Changliang. Clinical observation and nursing of Chinese medicine combined with recombinant interleukin-11 in treating refractory idiopathic thrombocytopenic purpura[J]. Journal of Clinical Medicine in Practice, 2014, (22): 31-34. DOI: 10.7619/jcmp.201422010

Clinical observation and nursing of Chinese medicine combined with recombinant interleukin-11 in treating refractory idiopathic thrombocytopenic purpura

  • ABSTRACT:Objective To explore the clinical curative effect and nursing of Chinese medicine combined with recombinant interleukin-2 in treating refractory idiopathic thrombocytopenic purpu-ra.Methods 52 renal anemia refractory idiopathic thrombocytopenic purpura patients were ran-domly divided into treatment group and control group.The treatment group with 26 cases was given subcutaneous injection of recombinant human interleukin-2(Juhe Granule)for 1 time daily,con-tinuous treatment lasted for 14 days per month and 1 months was a course of treatment.Besides, Chinese medicine decoction(composed of radix astragali,radix rehmanniae,herba agrimoniae,buf-falo horn,cortex moutan,callicarpa macrophylla vahl,etc)was orally taken for 1 agent daily for 2 times in the morning and evening.The control group with 26 cases was given only recombinant hu-man interleukin-2 (Juhe Granule).The course of the treatment in the two groups was lasted for 2 months and nursing intervention measures were conducted during the treatment.Results The ef-fective rate was 88.5% in the treatment group and 65.4% in the control group.Comparison of the two groups showed that the difference was statistically significant(P <0.05).Conclusion Chinese medicine combined with recombinant interleukin-2 in treating refractory idiopathic thrombocy-topenic purpura has significant curative effect.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return